
These will be glad tidings for MS&L’s client base. MS&L serves a global health clientele which includes companies in consumer health (J&J, P&G), biotech (Amgen and Genentech), pharmaceuticals (GSK, Eli Lilly), medical devices (Phillips), and health plans and providers (Kaiser, Partners).
Some of the findings include:
Health Populi’s Hot Points: These findings should be encouraging to consumer-facing health businesses…which include every health stakeholder in the U.S. at this stage in the market. Whatever form of health financing we have in the U.S., consumers need to play a larger role in decision making, co-paying and -financing, and partnering in the production of their individual health. Whether MS&L’s MAP model will help vendors to the industry help change consumers’ less-than-ideal health behaviors — versus their inner values for health as demonstrated by this survey — remains to be seen. But in the before-and-after photos we see this time of year to promote healthy eating and fitness, I’m hopeful MS&L can convert more Americans to “afters.” That must go beyond healthy eating and exercise; it goes for the entire spectrum of health engagement. If health engagement can become a status symbol, like carrying an iPod, a Jimmy Choo doctor bag (shown at left), or Bose quiet headphones, I’ll concede that we’re in consumer-driven health mode.




I'm gratified to be named on
I’m celebrating America’s 250th birthday both patriotically and professionally, honored that the NLM included my 2010 paper, “How Smartphones Are Changing Healthcare for Consumers and Patients” as one of 250 items curated for the digital archive of 250 Years of American Medicine.
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global health care enterprise.